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Abstract.  To examine the function of the c~d~4 integrin 
we have determined its ligand-binding  ability and 
overexpressed two potentially dominant negative mu- 
tant ~4 subunits,  lacking either the cytoplasmic or 
extracellular domain,  in bladder epithelial 804G cells. 
The results of cell adhesion and radioligand-binding 
assays showed that O/6~4 is a receptor for several lami- 
nin isoforms, including laminin  1, 2, 4, and 5.  Over- 
expression of the tail-less or head-less mutant J~4 
subunit did not suppress ota34-mediated  adhesion to 
laminins,  as both types of transfectants adhered to 
these ligands in the presence of blocking anti-Bt  anti- 
bodies as well as the controls.  However, immunotiuo- 
rescence experiments indicated that the endogenous 
Og6~4 integrin and other hemidesmosomal markers 
were not concentrated in hemidesmosomes in cells 
overexpressing tail-less/34,  while the distribution 
of these molecules was not altered in cells overex- 
pressing the head-less subunit.  Electron microscopic 
studies confirmed that cells overexpressing tail-less ~4 
had a drastically reduced number of hemidesmosomes, 
while cells expressing the head-less subunit had a nor- 
mal number of these structures.  Thus,  expression of a 
tail-less, but not a head-less mutant/~4  subunit leads 
to a dominant negative effect on hemidesmosome as- 
sembly without suppressing initial  adhesion to lami- 
nins.  We conclude that the c~/34 integrin binds to sev- 
eral laminins  and plays an essential role in the 
assembly and/or stability of hemidesmosomes, that 
otd34-mediated adhesion and hemidesmosome assembly 
have distinct requirements,  and that it is possible to 
use a dominant negative approach to selectively inter- 
fere with a specific function of an integrin. 
T 
FIE study of laminin binding  integrins  is of particular 
relevance  because many  of the effects of basement 
membranes on the proliferation  and differentiation of 
cells can be recapitulated  in vitro by laminins  (Manthorpe 
et al., 1983; Grant et al., 1989; Panayotou et al., 1989; yon 
der Mark and Ocalan,  1989;  Caron,  1990) or blocked by 
anti-laminin  antibodies in  cell and organ  culture  systems 
(Grover and Adamson,  1985; Klein et al.,  1988; Streuli et 
al.,  1991). Recent results  indicate  the existence  of several 
laminin isoforms, expressed in a tissue-specific fashion (Eng- 
vail et al.,  1990; Sanes et al.,  1990; Rousselle et al.,  1991; 
Marinkovich et al., 1992b). In addition,  at least six integrins 
have been implicated  in binding  to laminins  and,  in several 
cases, their binding specificity appears to be overlapping (for 
review see Mercurio,  1990; Hynes, 1992). The hypothesis 
that individual  laminin-binding  integrins  have distinct cyto- 
skeletal and signaling functions may help to explain the ap- 
parent redundancy  of the laminin  recognition  system. 
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There are several reasons for believing that the ctd34 inte- 
grin,  which has been implicated  in binding  to laminin  1 
(subunit  composition:  c¢~-/3t-~'l) and  laminin  5  (kalinin, 
epiligrin,  nicein;  tx3-/33-3,2) (Lee et al., 1992; Niessen et al., 
1994), is characterized  by unique intracellular  interactions. 
The cytoplasmic domain  of the/34  subunit  measures over 
100 kD in molecular mass and bears no homology with the 
short  cytoplasmic domains  of the  other  known  integrins 
(Hogervorst et al.,  1990; Suzuki  and Naitoh,  1990).  This 
portion  of the  molecule  contains  two  pairs  of type  III 
fibronectin-like  modules connected by a sequence (Connect- 
ing  Segment)  which  appears  to be the target  of multiple 
potential regulatory  mechanisms,  including alternative splic- 
ing (Tamura et al.,  1990) and proteolytic processing (Gian- 
cotti et al.,  1992).  Furthermore,  in contrast to/51  and/33 
integrins  which localize to focal adhesions  or otherwise in- 
teract  with the actin  filament  system  (Chen  et al.,  1985; 
Damsky et al., 1985; Giancotti et al., 1986a; Dejana et al., 
1988),  the ot~4 integrin  is found concentrated  in hemides- 
mosomes and,  thus,  may interact  with the keratin  filament 
system (Carter et al., 1990; Stepp et al., 1990; Sonnenberg 
et al.,  1991). 
By expressing  various  deletion  mutant  forms of the B4 
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that a critical function of the t4 cytoplasmic domain is to 
mediate the association of the integrin with the hemides- 
mosomal cytoskeleton (Spinardi et al.,  1993).  As the ex- 
tracellular domain of ct6~4 binds to basement membrane 
components,  and  the  specialized  cytoplasmic  tail  of /~4 
subunit interacts with the hemidesmosomal cytoskeleton, 
this  integrin may play  a  crucial  role  in the  assembly of 
hemidesmosomes and their linkage to the keratin filament 
system. 
Despite  their  functional importance,  relatively little is 
known about the molecular composition and mechanism 
of  assembly  of  hemidesmosomes.  In  addition  to  ad34, 
hemidesmosomes contain another transmembrane protein, 
the Bullous Pemphigoid Antigen 2  (BPAG2)  t  (Giudice et 
al.,  1992),  which may be  involved in  cell adhesion and 
hemidesmosome assembly. In fact, BPAG2 is a target of the 
pathogenic autoantibodies present in  patients  affected by 
BuUous Pemphigoid (Labib et al., 1986;  Liu et al., 1993), 
a blistering skin disease characterized by fragmentation and 
disappearance  of  both  hemidesmosomes  and  basement 
membrane (Schaumburg-Lever et al.,  1972).  The relative 
roles of the eta4 integrin and BPAG2 in the establishment 
of stable epidermal cell adhesion to the basement membrane 
and in the assembly of hemidesmosomes are presently un- 
clear. 
To analyze the function of the ct6/~4 integrin and its role in 
cell adhesion and assembly of  hemidesmosomes, we have ex- 
amined the  spectrum  of ligands  recognized by  t~d34 and 
tested two distinct strategies for creating a dominant negative 
mutant /~4 subunit.  We report  that ot~4  binds  to  several 
laminin isoforms.  Introduction of a  truncated tail-less /~ 
subunit in cells possessing endogenous ctdL integrins and 
hemidesmosomes led to a dominant negative effect, while 
comparable expression of a/~4 molecule lacking almost the 
entire extracellular portion did not.  Ceils  expressing the 
dominant negative tail-less form of/~ were found to have a 
drastically reduced number of hemidesmosomes, but did not 
show defective adhesion to laminins. 
Materials and Methods 
Cell Lines, Antibodies, and Extracellular 
Matrix Molecules 
Rat bladder carcinoma 804G cells (Izumi et ai.,  1981)  were cultured in 
DMEM with 10% bovine calf serum (BCS). RAC-11P/SD cells (Sonnen- 
berg et al.,  1993) were cultured in DMEM with 10% FBS. 
The monoclonai antibody 3El recognizes the extraceUular portion of hu- 
man, but not rodent integrin/34 subunit (Giancotti et al.,  1992). The other 
subunit-specific antibodies used in this study were all raised by immunizing 
rabbits with synthetic peptides reproducing COOH-terminal sequences and 
were shown to cross-react with rodent integrins. The antibodies to a~ and 
/~4 (Giancotti et al.,  1992), al  (Tarone et al.,  1993), ~2 (Defilippi et al., 
1992), ¢x3 (Klein et al.,  1993), c~5 and/~l (Giancotti and Ruoslahti,  1990), 
and ~v (Vogel et al.,  1993) were previously described. The antibody to u4 
was generated and characterized in the laboratory of Erkki Ruoslahti (La 
Jolla Cancer Research Foundation, La Jolla, CA). The adhesion-blocking 
rabbit antiserum against affinity isolated rodent a5/31 was previously de- 
scribed  (Bernardi  et al.,  1987).  The monoclonal antibody Ab-1,  which 
binds to an epitope of c-myc comprising the amino acid sequence EQK- 
LISEEDL (residues 410-419), was purchased from Oncogene Science, Inc. 
(Uniondale,  NY).  Human  autoantibodies  directed to the BuUous  Pem- 
1. Abbreviations  used in this paper: BPAG2, Bullous Pemphigoid Antigen 2. 
phigoid Antigen 230 kD were provided by Jo-David Fine (University of 
North Carolina, Chapel Hill, NC). The BPAG2-specific rabbit polyclonai 
antiserum was raised by immunization with a GST-fusion protein compris- 
ing the major antigenic determinant of the mouse protein in the laboratory 
of Jouni Uitto (Thomas Jefferson University, Philadelphia, PA). The mono- 
clonai antibodies 4C7  and 4El0  bind to the human cq  and /~t laminin 
subunits, respectively (Engvall et al., 1986). The monoclonal antibody C4 
is directed to the ~2 laminin chain (Hunter et al.,  1989). The rabbit poly- 
clonal antibody R-1301 was raised by immunization with a synthetic peptide 
from the ot  2 laminin subunit (Panlsson et al.,  1991).  The monoclonal anti- 
body 51-12 reacts with the 80-kD fragment of the same subunit (Leivo and 
Engvali, 1988). The monoclonal antibodies BM-165 (Rousseile et al., 1991) 
and BM-140 (Marinkovich et al.,  1992a) recognize the human a3 and/~3 
subunits, respectively. 
Human plasma fibronectin, mouse laminin 1 (purified from Engelbreth- 
Holm-Swarm tumor), and human placental laminin were purchased from 
GIBCO  BRL  (Gaithersburg,  MD).  The  human  placental  laminin  was 
purified according to Ehrig et al. (1990). Electrophoretic and immunoblot- 
ting analyses conducted in our laboratory have shown that it contains the 
c~2,/32, and ~/t chains, corresponding to laminin 4.  The same conclusion 
was reached in a recently published study (Sonnanberg et al., 1993). Immu- 
noblotting with monocional antibodies to the human cq,  /~l,  ct3, and/~3 
chains have indicated that this preparation was not contaminated by laminin 
1, 5, 7, or 8. Laminin 2 was purified to homogeneity from mouse heart in 
the laboratory of Mats Paulsson (University of Bern, Switzerland) by using 
previously published procedures (Panisson et al.,  1991).  Human laminin 5 
was purified to homogeneity from keratinocyte cell culture medium in the 
laboratory of Robert Burgeson (Harvard Medical School, Boston, MA). 
Laminin 5 matrices were prepared as described previously (Sonnenberg et 
al., 1993). Electrophoretic analysis and immunobiotting with antibodies to 
laminin isoforms and other adhesive iigands have shown that laminin 5 is 
by far the predominant protein in matrices of RAC-11P/SD cells (Sonnen- 
berg et al., 1993). Our own electrophoretic analysis indicated that the 165- 
kD ct3 chain, the 155-kD 72 chain, the 140-kD/~3 chain, and the 105-kD 
72 chain degradation product represent more than 95 % of the Coomassie 
blue stainable proteins present in such matrices. Most of the residual mate- 
rial migrates as a band of ~190 kD and possibly represents the precursor 
of the c~3 chain. 
Constructs and Transfections 
Expression constructs encoding wild-type and mutant truncated human ~4 
subunits were assembled in the eukaryotic expression vector pRC-CMV 
(Invitrogen Corp., San Diego CA) and were previously described (Spinardi 
et al.,  1993). The plasmid pCMV-/~4 A 854-1752 directs the expression of 
a ~4 molecule lacking almost the entire cytoplasmic domain. The plasmid 
pCMV-~4 A70-660 encodes a/~4 subunit in which most of the extracellular 
sequences were replaced by a  c-myc epitope tag. 
Rat bladder carcinoma 804G cells stably expressing a tail-less (clones 
B13, B23, and B29) or a head-less (clone F28) human/~4 subunit were 
obtained by transfection with pCMV-/~4 A 854-1752 and pCMV-/~4 A 70- 
660,  respectively (Spinardi et al.,  1993).  Transfection protocols were as 
previously described (Giancotti et al., 1994). Clones with high level expres- 
sion of recombinant J34 molecules were  selected by performing fluores- 
cence-activated cell sorting, immunofluorescence,  and immunoprecipita- 
tion analyses, as previously described (Spinardi et al.,  1993). The clone 
expressing a fuilqength human #4 subunit (clone A12) was previously de- 
scribed.  The control cell lines (clones Z10 and Z32) were generated by 
transfection with pRC-CMV alone. The transfected cell lines were main- 
tained in DMEM-10 % BCS supplemented with 400 ~g/ml of G418 and cul- 
tured for at least 48 h in the absence of the selective agent before all experi- 
ments. 
lmmunoprecipitation and Western Blotting Analysis 
For immtmoprecipitation of cell surface molecules, intact cells were labeled 
in suspension with 12sI by the lactoperoxidase-H202 method, as previously 
described (Giancotti and Ruoslahti,  1990). After washing, the cells were 
extracted for 45 rain on ice with lysis buffer containing 50 mM Tris (pH 
7.5),  150 mM NaC1, 0.5%  Triton X-100,  0.01%  Aprotinin (Sigma Chem. 
Co.,  St. Louis, MO), 4  tzg/ml Pepstatin A  (Sigma),  10/~g/ml Leupeptin 
(Sigma), 1 mM PMSF and 10 mM EDTA. For immunoprecipitation of in- 
tegrins other than c~c~4, lysis buffer contained 1 mM CaC12,  1 mM MgClz, 
and no EDTA. The immunoprecipitations were performed as previously de- 
scribed (Giancotti and Ruoslahti,  1990) and analyzed by SDS-PAGE.  All 
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was  performed with  X-Omat AR  films (Eastman  Kodak  Co.,  Roches- 
ter, NY). 
FOr Western blotting analysis, confluent monolayers were extracted on 
ice with lysis buffer.  The extracts were clarified and their protein content 
was determined by the BCA assay (Pierce, Rockford, IL). Samples contain- 
ing 6 mg of total proteins were immunoprecipitated with an excess of the 
/34 cytoplasmic peptide antibody. Samples containing 100/zg total proteins 
were precipitated with 6 vol of acetone. Both types of samples were sepa- 
rated by SDS-PAGE and subjected to immunoblotting according to previ- 
ously published procedures (Giancotti et al., 1992). Bound antibodies were 
detected by incubation with J25I-Protein  A (ICN Biomedicals, Irvine, CA) 
and autoradiograpby or by chemiluminescence  with ECL (Amersham Life 
Sciences, Little Chalfont, UK). 
To measure the expression of recombinant and endogenous integrins in 
the various clones, the radioactivity of immunoreactive bands in polyacryl- 
amide gels and nitrocellulose filters was quantified by a Pbosphorimager 
(Molecular Dynamics, Sunnyvale, CA). 
Adhesion Assay 
Adhesion assays were performed essentially as previously described (Gian- 
cotti et al.,  1985).  After coating, all plates were blocked with PBS-0.1% 
BSA (Sigma). To avoid synthesis and secretion of adhesion proteins during 
the assay, the ceils were treated with 20 I~M cyclobeximide (Sigma) for 1 h 
and with 1 #M monensin (Sigma) for 5 min before the assay.  Cells were 
detached by incubation in 0.25% trypsin (GIBCO BRL) for 5 min. After 
blocking with Soybean Trypsin Inhibitor (Sigma), the cells were washed 
and resnspended in serum free DMEM containing 20 t~M cycloheximide. 
For antibody inhibition experiments, the ceils were preincubated with the 
indicated concentrations of antibodies for 15 min at 4"C before plating. 
Ceils were added at  1-2  ×  105 per well and incubated for the indicated 
times at 37"C in an atmosphere containing 5% COz. Quantitation of the 
results was as previously described (Gianeotti et al.,  1986b). 
Radioligand-binding Assay 
The partially recombinant wild-type and tail-less c~6/~4 integrins used in 
radioligand-binding experiments were purified from the transfected 804G 
clones A12  and BI3,  respectively. Approximately 1.5  ×  109 cells were 
used for each purification. Cells were harvested by using 5 mM EDTA, 
washed, and solubilized with 10 ml of lysis buffer containing 50 mM Tris 
(pH 7.5),  150 mM NaCI, 200 mM n-Octyl-/~-D-Glucopyranoside (Caibio- 
them, San Diego, CA), 5 mM EDTA, 0.01% Aprotinin, 4/zg/mi Pepstatin 
A,  10 tzg/ml  Leupeptin, I  mM PMSF, and  1 mM MnCI2  for 45 min at 
O°C. Extracts were clarified by centrifugation at 15,000 rpm and incubated 
with 1 mi of Sepharose-normul IgG to remove proteins which bind non- 
specifically. The extracts were then applied to an affinity matrix prepared 
by cross-linking 5  mg of purified 3El  monoclonal antibody to  1 mi of 
Sepharose-Protein G (Pharmacia LKB Biotechnology, Piscataway,  NJ). Af- 
ter 4 h of incubation at 4"C, the unbound material was removed and the 
column was washed with 25 bed volumes of 50 mM Tris (pH 7.5), 150 mM 
NaCI,  50 mM n-Octyl-B-o-Glucopyranoside. The integrins were eluted 
with 5 bed volumes of 50 mM Triethylamine, pH 10,  150 mM NaCI, 50 
mM n-Octyl-B-D-Glucopyranoside  into tubes containing neutralizing buffer 
(10% by volume 1 M Tris-HC1,  pH 7.4).  Peak fractions were analyzed by 
SDS-PAGE and Coomassie blue staining, and pooled. Protein concentra- 
tion was estimated by comparison with known amounts of BSA. The purity 
was consistently higher than 95 %. 
Laminins 1, 2, 4, and 5 and fibronectin were radioiodinated by the iodo- 
gen method and separated from free iodine by Sephadex (325 (Pharmacia) 
gel filtration.  Protein peak fractions were analyzed by SDS-PAGE. The 
specific activity of the various preparations was determined by counting in 
a gamma counter a TCA-precipitated aliquot of the peak fractions. Specific 
activities were 1.3  ×  106 CPMs/#g for laminin i, 1.9  x  106 CPMs/I~g for 
laminin 2,  3.3  ×  106 CPMs/#g for laminin 4, 0.5  ×  106 CPMs/#g for 
laminin 5, and 9.9  ×  106 CPMs//~g for fibronectin. 
Purified integrins were diluted to 0.25/~g/ml with PBS containing 1 mM 
MnCI2.  Removable microtiter wells (Microtest III,  Falcon) were coated 
with 100 ~.1 of receptor solution (25 rig) overnight at 4°C. After blocking 
with 2 % BSA, the wells were incubated with the indicated amounts of radio- 
labeled matrix molecules diluted in PBS containing I mM MnC12 for 4 h 
at room temperature. When indicated, synthetic peptides or EDTA were in- 
eluded. At the end of incubation, the wells were washed five times with 
PBS, 1 Mm MnCI2 and counted in a gamma counter. Nonspecific binding 
was defined as the amount of radioligand which bound to wells coated with 
BSA only and was subtracted from each dose point. 
To determine the dissociation constant between laminin 4 and the wild- 
type or truncated tail-less integrin, displacement experiments were carried 
out. A single concentration of radiolabeled laminin 4 (100 ng/0.1 ml) was 
added to each well in presence of increasing concentrations of cold ligand 
(0-2.5 t,g/0.1  ml). The results were subjected to Scatehard analysis. 
Immunofluorescence 
The 804G transfectants were cultured for '~,48 h on glass coverslips, and 
then either fixed directly with cold methanol for 2 rain or treated with PBS 
containing 0.2% Triton X-100 for 5 rain on ice before fixation with metha- 
nol. Cells were stained for 45 min with the various antibodies. The purified 
anti-human #4 3El and anti-c-myc Ab-1 monoclonal antibodies were used 
at 5 ~g/ml. The anti-BPAG1 human serum and the c~6 cytoplasmic domain 
rabbit serum were diluted 1:200. The anti-BPAG2 fusion protein IgGs were 
used at 25 t~g/ml. The affinity-purified/34 cytoplasmic peptide antibodies 
were used at 5/~g/mi. After extensive washing, the cells were incubated for 
45  rain  with 0.5-1  /zg/rnl  of affinity-purified fluorescein isothiocyanate 
(FITC)-conjugated goat anti-mouse, anti-rabbit, or anti-human IgGs (Mo- 
lecular Probes Inc., Eugene, OR). The coverslips were mounted in Citi- 
Fluor (Chemical Laboratory of the University of Kent, Canterbury, UK). 
For double immunostaining with the 3El or Ab-1 monoclonal antibody 
and the anti-BPAG2 rabbit IgGs, the coverslips were incubated first with the 
monoclonal antibody followed by Texas  red (TR)-conjugated goat anti- 
mouse IgGs,  and  then with the anti-BPAG2  IgGs  followed by affinity- 
purified  FITC-labeled  goat  anti-rabbit  IgGs  (Molecular  Probes).  For 
double immunostaining with the 3El or Ab-1 monoclonal antibody and the 
anti-BPAGl  human  serum,  the coverslips were incubated first with the 
monoclonal antibody followed by affinity-purified TR-conjugated goat anti- 
mouse IgGs (Molecular Probes), and then with the anti-BPAG1 serum fol- 
lowed by FITC-labeled goat anti-human IgGs.  All secondary antibodies 
used were species-specific. Samples were examined with a Zeiss Axiophot 
Fluorescence Microscope. 
Electron Microscopy 
Cells grown on laminin 4--coated Aclar plastic coverslips were rinsed in 
PBS and fixed overnight at 4"C in 0.05 M Sodium Phosphate buffer, pH 7.0, 
containing 2% Glutaraldehyde and 0.1 M Sucrose. After washing in 0.1 M 
Phosphate buffer,  the coverslips were incubated in 2 % Osmium Tetroxide 
in 0.1 M Phosphate buffer for 1 h and embedded in Epon (Milner and Ba- 
con, 1989).  To obtain cross-sections of the cells, pieces of the embedded 
coverslips were reembedded in Epon in the appropriate orientation for sec- 
tioning. Ultrathin sections (50-65 nm) were collected on copper grids and 
counterstained with Uranyl Acetate and Reynold's Lead Citrate. Sections 
were analyzed on a Philips 201  electron microscope. 
Results 
Overexpression of Truncated/3, Integrin Subunits 
Previous results indicated that a truncated tail-less human 
#4 subunit (A cyto 874-1752) combines with endogenous or6 
and  reaches  the  cell  surface,  but  is  not  incorporated  in 
hemidesmosomes.  In  contrast,  a  truncated  head-less  /34 
subunit (A exo 70-660) does not associate with endogenous 
c~6, but is transported to the cell surface and recruited in 
hernidesmosomes (Spinardi et al., 1993).  We reasoned that 
the integrin containing the tail-less recombinant/34 subunit 
could exert a dominant negative effect by competing with en- 
dogenous wild-type c~4 for adhesive ligands. Conversely, 
the head-less recombinant/34 subunit could compete with 
the endogenous ~  receptor for binding to cytoskeletal 
elements or regulatory factors (Fig.  1): 
To test the potential dominant negative effect of truncated 
/34 subunits in hemidesmosome-forming cells, we selected 
804(3 clones with potential for high level expression of  either 
the tail-less (A cyto 874-1752) or the head-less (A exo 70- 
660)  human  ~4  subunit,  as  described  in  Materials  and 
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Figure 1. Schematic representation of wild-type and recombinant 
mutant c¢~4 integrins. (Top) Wild-type endogenous u~4 integrin. 
(Middle)  Hybrid heterodimer consisting of the recombinant tail- 
less  human  f14  subunit  (Acyto) and  associated  endogenous ct6 
subunit. (Bottom) Head-less human ~4 subunit (Aaw), which does 
not combine with endogenous ct6. The heterodimer containing a 
tall-less/~4 subunit is expected to compete with the endogenous 
integrin for binding to extracellular ligand. The head-less/~4 poly- 
peptide may instead compete with endogenous wild-type c¢6~4 for 
interaction with intracellular molecules. 
Methods.  The  transfectants  selected  for  study  included: 
clones  B13,  B23,  and  B29,  expressing  the  tail-less  /~4 
subunit;  clone F28,  expressing the head-less/34 molecule; 
and  clones  Z10  and  Z32,  transfected  with  the  selection 
marker alone. 
The level of expression of recombinant tail-less/~4 and 
endogenous wild-type/~4 in the various B clones was exam- 
ined by immunoprecipitation (Fig. 2 A). Control clones Z10 
and Z32, clone A12 which expresses a full-length human/34 
subunit and clones B13, B23, and B29 carrying the tail-less 
human f14 subunit were labeled at the surface with '~5I and 
extracted. Samples containing equal amounts of TCA-pre- 
cipitable counts were immunoprecipitated with  saturating 
amounts of the  3El  monoclonal antibody,  reacting selec- 
tively with the extracellular domain of human f14 (Fig. 2 A, 
left). The 3El monoclonal antibody did not bind to any mem- 
brane protein in control ceils, but immunoprecipitated high 
levels of recombinant full-length f14 from clone A12,  simi- 
larly high levels of tail-less ~4 from clone B13, and lower 
levels from clones B23 and B29. In accordance with previous 
results indicating that the c~6 subunit is poorly labeled by 
cell surface iodination,  the  ll0-kD  a6  subunit associated 
with full-length and tail-less recombinant/34 could be de- 
tected only upon prolonged exposure of the gel. 
To compare the  expression of recombinant  tail-less  f14 
with  that of endogenous wild-type /t4, the various clones 
were also immunoprecipitated with excess amount of a poly- 
clonal antiserum raised against a synthetic peptide reproduc- 
Figure 2. Immunoprecipitation analysis of recombinant f14 molecules expressed in 804G cells. (A) The indicated clones were labeled 
with '251 and extracted with lysis buffer. Aliquots containing the same amount of TCA precipitable radioactivity were immunoprecipi- 
tated with an excess amount of the 3El monoelonal antibody or the c~a cytoplasmic domain antiserum. Samples were separated by 
SDS-PAGE  under reducing conditions and subjected to autoradiography. (B) The indicated clones were either directly extracted in sam- 
ple buffer (TOT) or immunoprecipitated with the/~4 cytoplasmic peptide antibody before electrophoresis (IP). The lanes marked TOT 
contain 100/~g of total proteins, while those labeled IP contain the material immunoprecipitated from 6 mg of total proteins. Both 
types of samples were separated by SDS-PAGE  under reducing conditions and probed by immunoblotting with affinity-purified  ~4 cy- 
toplasmic peptide antibodies. Bound antibodies were detected by incubation with '25I-Protein A followed by autoradiography. 
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was selected because ot~ is the only or6 subunit isoform ex- 
pressed in 804G cells (unpublished results).  As shown in 
Fig.  2  A  (righO, the  antiserum  immunoprecipitated  two 
types of ot~ heterodimers from the B clones: those contain- 
ing the 100-kD recombinant tail-less 134 molecule and those 
containing the  200-kD  wild-type  endogenous  /34  subunit. 
Phosphorimager analysis indicated that the recombinant tail- 
less/3, subunit was  1.6 times more abundant than endoge- 
nous/3, at the surface of clone B13, but endogenous 134 was 
3.2 and 3.4 times more abundant than the recombinant mole- 
cule in clones B23 and B29, respectively. It was concluded 
that tail-less/3, is  overexpressed in clone B13,  but not in 
clones B23 and B29. 
The level of recombinant/34 lacking the extracellular do- 
main expressed in clone F28 was  examined by performing 
immunoblotting experiments with an antibody raised against 
a synthetic peptide designed after the COOH terminus of hu- 
man/34.  This/34 cytoplasmic domain antibody was expected 
to react well with both the human head-less/34  molecule 
and  the endogenous rat wild-type /34  subunit,  because its 
target sequence is conserved in rodents and humans (Kennel 
et al.,  1993). To obtain two distinct measurements of differ- 
ent sensitivities, cells of the control clone Z10 and the head- 
less 134 expressing clone F28 were either directly extracted 
in sample buffer or immunoprecipitated with excess amount 
of the/34 cytoplasmic domain antibody before immunoblot- 
ting.  The/34 cytoplasmic domain antibodies bound to the 
recombinant head-less/34 subunit in clone F28 and reacted 
with  endogenous  wild-type  134  in  total  extracts  and  im- 
munoprecipitates  from both control clone Z10  and  clone 
F28. Fainter bands at ,o70 kD, possibly representing proteo- 
lyric fragments of f14, were also detected (Fig. 2 B). Phos- 
phorimager  analysis  indicated  that  the  head-less  recom- 
binant molecule is expressed at levels 5.3 times higher than 
endogenous  /3,  in  clone  F28.  From  this  experiment,  we 
concluded that the recombinant head-less subunit is overex- 
pressed in clone F28. Although the ratios of recombinant to 
endogenous/34 subunits in clones F28 and B13 were deter- 
mined by different methods, the results suggest that the ex- 
tent  of  overexpression  of  head-less  /3,  in  clone  F28  is 
greater than that of tail-less ~, in clone B13. 
The ad34 Integrin Is a Receptor for Laminins 
1, 2, 4, and 5 
To examine the effects of the truncated/34 subunits on o~d34- 
mediated cell adhesion, we sought to define the ligands of 
txd34 and  determine  which  integrins  with  an  overlapping 
ligand-binding specificity were expressed by 804G cells. The 
repertoire of integrins expressed by 804G cells was exam- 
ined by immunoprecipitation. After labeling of the cell sur- 
face with ~2sI, the 804G cells were extracted and immuno- 
precipitated with antibodies to synthetic peptides modeled 
after various integrin cytoplasmic domains. As shown in Fig. 
3, the results indicated that 804G cells express high levels 
of the t~3/3~ and otd3, integrins and lower levels of ct2/3~. A 
prolonged exposure of the gel (lane to the far right in Fig. 
3) revealed that they also express minor levels of cry/31. No 
/3~ subunit could be detected in association with ~6, even af- 
ter prolonged exposure of the gel, indicating that 804G cells 
do not express the ctd3~ integrin. 
Cell adhesion assays showed that the 804G cells adhere 
Figure 3. Immunoprecipitation analysis of integrins expressed by 
804G cells.  Parental 804G cells were labeled with  1251 and ex- 
tracted with lysis buffer. Aliquots containing the same amount of 
TCA precipitable radioactivity were immunoprecipitated with the 
indicated subunit-specific anti-integrin antibodies. Samples were 
separated by SDS-PAGE under nonreducing conditions and sub- 
jected to autoradiography. Immunoprecipitation with the anti-or6 
antibody yielded,  in addition to intact/34,  two proteolytic frag- 
ments of 170 and 140 apparent mol wt. In agreement with previous 
results (Giancotti et al.,  1992), these fragments were not recog- 
nized by the 134 cytoplasmic domain antibody because they lack 
the  corresponding epitope.  The results of an 8-h exposure are 
shown except for the lane to the far right which represents a 36-h 
exposure of the c~v immunoprecipitation. 
well to fibronectin, type IV collagen, and laminin 4, but in- 
teract more weakly with laminin 1 and 2 (Fig. 4 A). In addi- 
tion, time course experiments indicated that 804G cells ad- 
here well to the laminin 5 matrix deposited by RAC-11/PD 
cells (Fig. 4 B). Although the matrix form of laminin 5 can- 
not be directly compared to the other purified soluble mono- 
meric ligands tested, these results clearly show that the 804G 
cells can interact well with laminin 4  and 5, and less well 
with laminin 1 and 2.  Since the adhesion of 804G cells to 
the laminin 5 matrix and to laminin 4 was not affected by an- 
tibodies reacting with rat/31  (Fig. 4  C), we concluded that 
adhesion to laminin 4 and 5 could involve o~d34. 
To directly test the ligand-binding ability of the c~d34 inte- 
grin in the absence of potentially confounding influences of 
other integrins or cellular regulatory factors, radioligand- 
binding  assays  were performed.  A  partially  recombinant 
form of the ot~4 integrin was purified from clone A12 cells 
by immunoaflinity chromatography on the 3El monoclonal 
antibody, as described in Materials and Methods. Mierotiter 
wells were coated with 25 ng of purified integrin, and then 
incubated with various concentrations of iodinated laminin 
1, 2, 4, and 5 or fibronectin. The laminin 5 used in this ex- 
periment was immunopurified to homogeneity and did not 
contain detectable amounts of laminin 6, the laminin isoform 
to which laminin 5 is covalently associated in tissues.  The 
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cause this cation was previously reported to effectively sus- 
tain  the  ligand-binding  function  of otd34 (Niessen  et  al., 
1994). The results of this experiment indicated that purified 
o~d~4 binds in a dose dependent way to laminin 1, 2, 4, and 
5 (Fig. 4 D). Binding to laminin 4 and 5 was larger than that 
to laminin 1 and 2 suggesting a hierarchy of binding activi- 
ties  between  the  various  c~d34 ligands.  However,  affinity 
constants could not be directly extrapolated from these data, 
since no curve reached saturation.  The binding of erda4 to 
laminin 1, 2, 4, and 5 was specific, since the integrin did not 
bind to fibronectin (Fig. 4 D) and the binding observed with 
laminins could be prevented by 1 mM EDTA. A  synthetic 
peptide reproducing the major cell binding sites in fibronec- 
tin (GRGDSP) did not interfere with the binding of laminin 
4  to a~4 suggesting that this integrin,  like other laminin- 
binding integrins, is not RGD dependent (not shown). Taken 
together, these observations indicate that the otd~4 integrin 
binds to several laminin isoforms, including laminin 1, 2, 4, 
and 5. 
The Tail-Less ol~, Integrin Displays an Intact Affinity 
for ExtraceUular Ligand In Vitro 
The hypothesis that a recombinant tail-less form of 134 can 
suppress the function of endogenous c~d34 was based on the 
assumption that the tail-less integrin would be able to bind 
effectively to extracellular ligand.  To test this assumption, 
we purified  the  receptor  containing  a  tail-less  human  /34 
subunit from clone B13 and the receptor containing a full- 
length  human/~4  subunit  from clone  A12,  and  compared 
their binding properties by using a radioligand-binding as- 
say. Microtiter wells were coated with 25 ng of the two recep- 
tors and incubated with 100 ng of radioiodinated laminin 4 
in the presence of various concentrations of cold ligand. As 
shown in Fig. 5, A and B, the binding of radioactive laminin 
4 to both receptors was effectively competed by excess cold 
ligand. In both cases complete inhibition of binding was ob- 
served with ~3.5 pmol, corresponding to a 250-fold excess 
of cold over radioactive laminin 4. The displacement curves 
generated by the tail-less and wild-type receptor were very 
similar, suggesting that the two receptors bind to ligand with 
similar kinetics.  Scatchard analysis of the results indicated 
that the two receptors display a very similar affinity for lami- 
nin 4  (Fig.  5,  C and D). Indeed, the estimated Ka of wild- 
type receptor was 8.45  ×  10  -s mol/liter and that of tail-less 
receptor was 7.04  ×  10  -s mol/liter.  These results demon- 
strate that the truncated tail-less erda4 integrin retains an in- 
tact ligand-binding ability in vitro and indicate that deletion 
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Figure 4. Ligand-binding spec- 
ificity  of the  c¢d34 integrin. 
(A) Parental  804G cells were 
plated  for  30  min  at  37°C 
on  microtiter  wells  coated 
with  increasing  concentra- 
tions of the indicated purified 
matrix proteins. The extent of 
cellular  adhesion  was  deter- 
mined  by measuring  the  ab- 
sorbance generated by the at- 
tached  cells,  as described  in 
Materials  and  Methods.  (B) 
The 804G cells were plated on 
wells coated with the laminin 
5  matrix  deposited  by  the 
RAC-11/PD  cells,  with  20 
#g/nil  of fibrone~tin,  or  20 
/~g/ml of laminin  4  and  in- 
cubated at 37°C for the indi- 
cated varying times.  (C) The 
804G cells were plated for 1 h 
at 37°C on wells coated with 
the laminin 5 matrix, 2/zg/ml 
of fibronectin  or 6 /~g/rnl of 
laminin  4  in presence  of the 
indicated  dilutions  of  anti- 
beta 1 antiserum.  These con- 
centrations  of fibrone~tin and 
laminin  4  were  chosen  for 
coating  because  preliminary 
experiments  had  indicated 
that  they  were  able  to  pro- 
mote, in a l-h assay conducted 
in the absence of anti-beta  1 
antibodies, an extent of cell adhesion comparable to that observed on the laminin 5 matrix.  The 0 point on the abscissa corresponds to 
the values measured in the absence of blocking antibodies. All the adhesion assays were conducted in triplicate and standard deviations, 
and did not exceed 22 % of each mean value. (D) Microtiter wells were coated with purified, partially recombinant c~c~4 integrin (25 tag/ 
well) and incubated with the indicated concentrations of radiolabeled ligands in presence of 1 mM MnCI2 for 4 h at room temperature. 
Bound  ligand  was measured  in  a gamma counter.  Each point  represents  the  mean of duplicates  from a representative  experiment. 
Nonspecific binding did not exceed 25 % of total binding and was subtracted  for each dose. 
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Figure 5. Scatehard analysis of 
laminin 4 binding to partially 
recombinant,  wild-type  and 
tall-less  o~4 integrin.  A con- 
stunt concentration of radiola- 
beled laminin 4 was incubated 
in wells coated with 25 rig/0.1 
ml  of  the  partially  recom- 
binant,  purified  wild-type or 
tail-less  integrin.  Displace- 
ment of radiolabeled  laminin 
4 was measured as a function 
of  increasing  concentrations 
of cold  ligand  added  (0-2.5 
/~g/0.1 ml). Nonspecific bind- 
ing was calculated by measur- 
ing  binding  to  wells  coated 
with BSA alone and was sub- 
tracted  from  each  point. 
Results  shown  represent  the 
mean of duplicates.  (A)  Dis- 
placement  curve of wild-type 
integrin;  (B)  displacement 
curve of tail-less  integrin; (C) 
Scatehard  plot  of  wild-type 
integrin; (D) Scatchard plot of 
tall-less  integrin. 
of the  /~4  cytoplasmic  domain  does  not  result  in  a  gross 
conformational  change  in  the  extracellular  domain  of the 
integrin. 
High-Level Expression of Head-Less or Tail-Less 
Recombinant [34 Does Not Suppress ~dJc-dependent 
Adhesion and Spreading 
To  test  the  effects  of  the  two  recombinant  truncated  /~4 
subunits on cell adhesion,  adhesion assays were performed 
with  the  control  clone  Z10,  the  head-less  /~4  expressing 
clone F28,  and the tail-less/~4  expressing  clones B13,  B23, 
and  B29.  To selectively  analyze the  function  of c~d~4, the 
cells were plated on laminin 4 and 5 in the presence of anti- 
bodies capable of blocking endogenous/3,  integrins.  Fig.  6 
A  shows that the clones  B13,  F28,  and B29 adhered to the 
laminin 5 matrix deposited by the RAC-11/PD cells with ki- 
netics and to an extent similar to that of control clone Z10. 
In addition,  the clones B13,  F28,  and B29 adhered to wells 
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Figure 6. Measurement  of c~d~4-dependent adhesion in cells expressing  the head-less  or tail-less  recombinant/3, subunit.  The indicated 
clones were incubated  in presence of a  1:50 dilution  of the anti-beta  1 antiserum  for varying times on wells coated with the laminin  5 
matrix CA), in presence of a 1:50 dilution of the anti-beta  1 antiserum for 30 min on wells coated with varying mounts of laminin 4 (B), 
or in the absence of anti-beta  1 antiserum for 30 min on wells coated with varying amounts of fibronectin (C). The assays were conducted 
in triplicate and standard deviations  did not exceed 18% of each mean value.  The lower maximal  adhesion observed in C reflects a lower 
input of cells in this particular experiment. 
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fibronectin (Fig. 6  C) to an extent similar to that of control 
clone Z10.  Thus,  neither  the head-less  nor the tail-less/34 
subunit  can  suppress  a6B4-dependent  adhesion  to  laminin 
4or5. 
Overexpression of  a Mutant [34 Subunit 
Lacking ExtraceUular Sequences Does Not 
Affect Hemidesmosome Assembly 
To determine  if high  level  expression  of the  head-less  /~4 
integrin  subunit  affects  the  assembly  and/or  stability  of 
Figure  7.  Immunofluorescent 
detection  of recombinant  full- 
length  and  head-less  ~4  sub- 
units  in  hemidesmosomes. 
Ceils  of the control clone Z10, 
the  full-length  /34  expressing 
clone A12, and the head-less/L 
expressing  clone F28 were cul- 
tured  on  glass  coverslips  for 
48 h, and then were either fixed 
directly with cold methanol  (A 
and B) or extracted  with 0.2% 
Triton X-100 before fixation  in 
methanol  (C-H). Clone  AI2 
cells were stained with the anti- 
human/~4 monoclonal antibody 
3El (A) and clone Z10 with the 
anti-c-myc  monoclonal  anti- 
body  Ab-1 (B)  followed  by 
FITC-conjugated  goat  anti- 
mouse  IgGs.  Clone  AI2 cells 
were  doubly  stained  with  the 
3El  monoclonal antibody and 
the rabbit anti-BPAG2 antibody 
followed  by  Texas red-conju- 
gatexl goat anti-mouse IgGs and 
FITC-labeled  goat  anti-rabbit 
IgGs  (3El  staining  in  C,  and 
BPAG2 staining  in  E).  Clone 
F28 cells  were doubly stained 
with  the  monoclonal antibody 
Ab-I and with  the rabbit anti- 
BPAG2  antibody  followed  by 
Texas red-conjugated goat anti- 
mouse IgGs and  FITC-labeled 
goat  anti-rabbit  IgGs  (Ab-1 
staining in D, and BPAG2 stain- 
ing in F).  Clone AI2 and F28 
cells  were  also  stained  with 
anti-BPAG1  human  antibodies 
followed by FITC-labeled goat 
anti-human IgGs (G and H, re- 
spectively). 
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of the head-less/34 and that of two cytoskeletal markers of 
hemidesmosomes, BPAG1 and 2, in clone F28 cells with the 
distribution of recombinant fulMength/34 and BPAG1 and 2 
in clone A12 cells. As shown in Fig. 7 A, immunofluorescent 
staining with the 3El monoclonal antibody indicated that the 
recombinant  full-length  /34  subunit  is  concentrated  at  the 
basal surface of clone A12 cells within granular structures, 
possibly  representing  individual  hemidesmosomes.  These 
structures  often  merged  into  patches,  but  were  excluded 
from circular  areas  thus  generating  a  distinctive  "Swiss- 
cheese'-like pattern.  Extraction of clone A12 cells with a 
buffer containing 0.2% Triton X-100,  before fixation and in- 
cubation with the 3El monoclonal antibody, did not affect the 
intensity of the staining associated with hemidesmosomes, 
but eliminated the immunofluorescence originating from the 
cytoplasm or  the  plasma membrane  outside  hemidesmo- 
somes (Fig. 7 C), indicating that the recombinant full-length 
/34 subunit  within  hemidesmosomes is largely resistant  to 
extraction with nonionic detergents. Double immunofluores- 
cent staining with the 3El  monoclonal antibody and with 
rabbit polyclonal antibodies  to  BPAG2  revealed a  precise 
colocalization  of  the  recombinant  /34  molecule  and  the 
hemidesmosomal marker in the Triton X-100 resistant struc- 
tures  (Fig.  7,  C and E).  In addition,  immunofluorescence 
with antibodies to BPAG1 resulted in a staining pattern simi- 
lar to that generated by the 3El and BPAG2 antibodies (Fig. 
7 G). These results indicate that the recombinant full-length 
/34 subunit and BPAG1 and 2 colocalize in hemidesmosomes 
in clone A12 cells and that within these structures these mol- 
Figure 8. Lack of detection of recombinant tail-less/~4 subunit and endogenous c~6 and/~4 subunits in hemidesmosomes in clone B13. Cells 
of the tail-less/~4 expressing clone B13 were cultured on glass coverslips for 48 h, and then were either fixed with cold methanol (A) or 
extracted with 0.2%  Triton X-100 before fixation in methanol (B, D, and E). Cells of the control clone Z10 were extracted with 0.2% 
Triton X-100 before fixation in methanol (C and F). Clone B13 cells were stained with the anti-human 84 3E1 monoclonal antibody fol- 
lowed by FITC-conjugated goat anti-mouse IgGs (,4 and D). Cells of the B13 and Z10 clones were stained with the a6 (B and C) or the 
84 cytoplasmic domain antibody (/~ and F) followed by FITC-labeled goat anti-rabbit IgGs. 
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X-100. 
We next analyzed the subcellular distribution of the over- 
expressed  recombinant  head-less  ~4  subunit  and  BPAG1 
and 2  in clone F28 cells. The transfectants were extracted 
with Triton X-100 and stained with the monoclonal antibody 
Ab-1  reacting with the c-myc epitope tag included in this 
recombinant truncated R4  molecule.  The antibody gener- 
ated negligible staining in control ceils of the Z10 clone (Fig. 
7 B), but reacted prominently with hemidesmosomal struc- 
tures in clone F28 cells (Fig. 7 D). Double immunostaining 
experiments demonstrated  a  precise  colocalization of the 
recombinant head-less ~4 with BPAG2  (Fig.  7,  D  and F), 
BPAG1 (Fig. 7 H, BPAG1 staining only is shown), and the 
endogenous a6 subunit (not shown).  These results suggest 
that the overexpressed recombinant head-less ~4 subunit ac- 
cumulates in hemidesmosomes without causing any appar- 
ent redistribution of the endogenous ot~4 integrin and the 
BPAG1 and 2 antigens normally associated with hemidesmo- 
somes. 
Electron microscopic analyses were conducted to examine 
the  structural  integrity of hemidesmosomes in  clone F28 
cells.  Cells of the control clone Z10 and the head-less ~4 
expressing clone F28  were cultured for 48  h  on laminin 
4-coated Aclar coverslips, and then fixed. Vertical sections, 
cut perpendicularly to the substratum, were examined with 
the  electron microscope.  The results  showed that control 
cells had a number of submembranous densities associated 
with the basal cell surface in correspondence of substratum 
attachment sites (see Fig.  11 A).  The appearance of these 
structures was  similar to that of the previously described 
hemidesmosomes in 804G cells in that they contained a rela- 
tively well defined inner plaque (Ridelle et al.,  1991).  A 
double-blind analysis indicated that the clone Z10 had an av- 
erage of 6.6 hemidesmosomes per cell section. Analysis of 
clone F28 cells indicated that these structures were neither 
significantly diminished (6.2 per cell per vertical section) nor 
altered (Fig.  11 B). Thus, Z10 and F28 cells appear to have 
similar  numbers  of normally  appearing hemidesmosomes. 
From the immunofluorescence and electron microscopy ob- 
servations, we concluded that expression of a head-less/~4 
subunit, at levels 5.3-fold higher than those of endogenous 
wild-type/34, does not affect hemidesmosome assembly and/ 
or stability. 
Overexpression  of  a Mutant {J4 Subunit LacMng the 
Cytoplasmic Domain Disrupts Hemidesmosomes 
Immunoflorescence experiments were performed to deter- 
mine if the tail-less recombinant ~4 subunit has a dominant 
Figure 9. Lack of detection of BPAG1 and BPAG2 in hemidesmosomes in clone B13. Cells of the tail-less/34 expressing clone BI3 (,4 and 
B) or the control clone Z10 (C and/9) were cultured on glass coverslips for 48 h, extracted with 0.2% Triton X-100, and then fixed in 
methanol. The cells were stained with the rabbit anti-BPAG2 antibody followed by FITC-labeled goat anti-rabbit IgGs (A and C) or with 
human antibodies to BPAG1 followed by FITC-labeled goat anti-human IgG (B and D). 
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of BPAG2 in clones expressing 
different levels of recombinant 
tail-less  /34. Control  clone 
Z10 (A), clones B29 (B), and 
B23 (C) which express mod- 
erate levels of tail-less/~4, and 
clone B13 (D), which expresses 
high  levels of  tail-less  /~4, 
were cultured on glass cover- 
slips for 48 h, extracted with 
0.2% Triton X-100, and then 
fixed in methanol.  The cells 
were  stained  with the  rabbit 
anti-BPAG2 antibody followed 
by  FITC-labeled  goat  anti- 
rabbit IgGs. 
negative effect on hemidesmosome assembly and/or stabil- 
ity. Staining of clone B13 cells with the 3El monoclonal anti- 
body indicated that the tail-less recombinant f14 subunit was 
diffusely distributed at the surface of these cells (Fig. 8 A). 
Extraction with 0.2 % Triton X-100 before fixing and antibody 
incubation  resulted in  an almost-complete loss  of staining 
(Fig.  8 D). Thus, in contrast to the recombinant wild-type 
/~4 which is largely insoluble in Triton X-100,  the tail-less 
/34 subunit is soluble in nonionic detergent, presumably be- 
cause it cannot establish proper cytoskeletal connections. 
We next wondered if expression of the tail-less  mutant 
subunit could affect the incorporation in hemidesmosomes 
of wild-type endogenous c~/~4. Cells  of the control clone 
Z10 and the tail-less f14 expressing clone B13 were treated 
with Triton X-100 and stained with affinity-purified antibod- 
ies to synthetic peptides  reproducing the cytoplasmic do- 
main of either as or ~4.  As shown in Fig.  8, B and E, al- 
though some punctuate staining was occasionally observed 
(arrows),  neither antibody detected significant amounts of 
o~d34 at  the basal  surface of clone B13  cells.  In  contrast, 
both antibodies  generated a  swiss-cheese-like staining  in 
clone Z10 cells (Fig. 8, C and F). This finding suggests that 
expression of tail-less/~4 prevents the incorporation of en- 
dogenous o~d~4 integrin in hemidesmosomes. 
To examine the integrity of hemidesmosomes in cells over- 
expressing the tail-less/34 subunit, cells of the control clone 
Z10 and of the tail-less/34 expressing clone B13  were ex- 
tracted with  Triton X-100 and  stained  with  antibodies  to 
BPAG1 and 2. As shown in Fig. 9, A and B, the two hemides- 
mosomal proteins were largely absent from the basal surface 
of Triton X-100-treated cells of the B13  clone.  Although 
some residual granular staining could be detected in a minor 
percentage of cells, the BPAG1 and 2 positive granules de- 
tected in clone B13 were limited to restricted areas of the 
basal surface (arrows in panels A and B) and rarely gener- 
ated a  Swiss-cheese-like pattern (open arrow in panel A). 
Moreover, the general distribution of BPAG2 was less altered 
than that of BPAG1. In contrast with the results obtained with 
clone B13, both the BPAGI and the BPAG2 antibody gener- 
ated a Swiss-cheese-like staining at the basal surface of con- 
trol clone Z10 (Fig. 9, C and D). Control immunoprecipita- 
tion experiments from metabolically labeled cells indicated 
that the biosynthesis of  BPAG1 and BPAG2 was not decreased 
in clone B13  as compared to control clones Z10 and Z32 
(data not shown). These results suggest that expression of  the 
tail-less mutant integrin subunit interferes with the assembly 
or stability of hemidesmosomes. 
To  determine  if  the  extent  of disruption  of hemides- 
mosomal markers in cells expressing the tail-less 84 subunit 
was  proportional to the level of expression,  we analyzed 
clones B29 and B23, in which the ratio of recombinant tail- 
less/~4 to endogenous/~4 is 5 times lower than in clone B13. 
Cells of the control clone ZI0 and tail-less  /~4 expressing 
clones B13, B29, and B23 were treated with Triton X-100 and 
stained with antibodies to BPAG2. As shown in Fig.  10, the 
altered distribution of BPAG2 was much less pronounced in 
clones B29 (panel B) and B23 (panel C) than in clone B13 
(panel D), and in many instances the granular basal staining 
generated by the two antibodies merged at least partially into 
patches and occasionally into a  Swiss-cheese-like pattern. 
Thus, the effect of tail-less/34 on hemidesmosomes is pro- 
portional to its level of expression. 
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hemidesmosomes, cells of  the control clone Z10 and the tail- 
less  B4  expressing  clone  B13  were  cultured  for  48  h  on 
laminin 4-coated Aclar coverslips and analyzed by electron 
microscopy. The result of these experiments  indicated that 
clone B13 cells had a greatly diminished number of submem- 
branous densities  associated with the basal  cell surface as 
compared with cells of the control clone Z10 (Fig.  11, C and 
D). A double-blind evaluation of the results  indicated  that 
clone B13 cells contain an average of 0.12 submembranous 
Figure  11. Electron microscopic analysis of ceils expressing  the recombinant head-less  or tail-less/34 subunit,  The control clone Z10 (A), 
the head-less  84 expressing  clone F28 (B), and the tail-less/~4 expressing  clone B13 (C and D) were grown for 48 h on laminin 4-coated 
Aclar plastic  coverslips.  Cross-sections  of the cells were obtained and processed for electron microscopy as described in Materials  and 
Methods.  Large arrowheads  in A point to hemidesmosomal structures  at the basal surface  of the control clone Z10. Small arrcm,  heads in 
B point to similar  structures  at the basal  surface  of clone F28 cells.  Bars: (A and B) 0.25  #m; (C)  1 tim; (D) 0.5 t~m. 
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well organized as the hemidesmosomes of clone Z10 an F28 
and rarely contacted the substratum (see Fig.  11 D for one 
example). Since the immunofluorescence studies indicated 
that the distribution of BPAG2 is less disrupted than that of 
other hemidesmosomal components in clone B13, it is possi- 
ble that the residual submembranous densities detected in 
this clone during the electron microscopic analysis represent 
small aggregates of BPAG2. Finally, it was evident from the 
electron microscopic analysis that clone B13 cells did not 
form an extended contact with the  substratum and were 
rounder than control cells (Fig. 11 C). Thus, although clone 
B13 cells can adhere well after being plated on laminin 4 and 
5 for the short incubation times of the adhesion assay (see 
for example Fig. 6 A and B), they acquire a less adhesive 
morphology after a more prolonged period of culture. Taken 
together, the results of the immunofluorescence and electron 
microscopic analyses indicate that expression of a  mutant 
tail-less/3, subunit disrupts the hemidesmosomes of 804G 
cells, and that this disruption is accompanied by the acquisi- 
tion of a less adhesive morphology as compared to that of 
control cells. 
Discussion 
In this study we report that high-level expression of a recom- 
binant tail-less integrin/34  subunit in 804G bladder epithe- 
lial cells disrupts hemidesmosomes without affecting otd3,- 
mediated adhesion. Therefore, the tail-less/34 subunit is a 
dominant negative mutant which selectively interferes with 
the association of the ot6/3, integrin with the hemidesmo- 
somal cytoskeleton without perturbing  its adhesive func- 
tion. Two major conclusions can be drawn from this result. 
The  first is  that the ot034 integrin plays a  crucial  role in 
promoting  the  assembly  or  maintaining  the  stability  of 
hemidesmosomes: indeed ot~, appears  to be a  necessary 
component of these  structures,  as  its function cannot be 
replaced by the other transmembrane element of hemides- 
mosomes, BPAG2. The second major conclusion is that the 
ligand-binding function of the ~d3,  integrin, as measured 
by adhesion assay, does not require stable association with 
the hemidesmosomal cytoskeleton. Thus, the ot~/34 integrin 
appears to be regulated differently from/3, and 132 integrins 
which need to associate with the cytoskeleton to mediate 
efficient cell adhesion in vivo (Hayashi et al.,  1990;  Hibbs 
et al.,  1991). 
To analyze the consequences of dominant negative inhibi- 
tion of ot6/34, we have conducted adhesion assays with the 
parental 804G cells and radioligand-binding studies with the 
purified partially recombinant otd34 integrin. A major con- 
clusion resulting from these experiments is that, in addition 
to laminin 5 and 1, o~d3, binds to laminin 2 and 4. Indeed, 
the affinity constant for binding to laminin 4 that we mea- 
sured,  8.45  x  10  -8 mol/liter, is higher than that reported" 
for the binding of the ot5/3, integrin to fibronectin (Hautanen 
et al.,  1989).  The observation that ctd3, is a  receptor for 
laminin 2 and laminin 4 may help to understand the function 
of this integrin in Schwann cells. It has been proposed that 
ot6/3,-mediated adhesion to the basement membrane plays a 
crucial role during myelination, because the expression of 
ot6/34 is rapidly induced in Schwann cells at the onset of this 
process (Einheber et al., 1993). Since the Schwann cell base- 
merit membrane does not contain laminin I or 5, but laminin 
2  and in a  lesser amount laminin 4  (Sanes et al.,  1990; 
Marinkovich et al., 1992b),  our current results suggest that 
otd34 interacts with these latter ligands during myelination. 
In  fact,  it  is  possible  that  otd34-mediated recognition  of 
laminin 2 and 4 provides the Schwann cells with a signal re- 
quired for myelination since the dy/dy mice, which lack the 
laminin or2 chain in both the muscle' and the Schwann cell 
basement membranes (Sunada et al., 1994; Xu et al., 1994), 
develop a form of muscular dystrophy accompanied by pe- 
ripheral nerve degeneration. 
Our binding studies indicate also that the ot6/34 integrin 
binds to laminin 1 and laminin 5. The presence of laminin 
5 in the anchoring filaments of hemidesmosomes (Rousselle 
et  al.,  1991) and  the  ability  of cell  lines,  which  form 
hemidesmosomes in vitro, to deposit high amounts of this 
matrix molecule on the culture substratum (Langhofer et al., 
1993; Sonnenberg et al., 1993) suggest that binding of a6/34 
to laminin 5 may be crucial for hemidesmosome assembly. 
In accordance with this hypothesis, it has been shown that 
antibodies  which  interfere with the  adhesive  function of 
~6/3, can reduce hemidesmosomes in cultured cells and in 
vivo (Jones et al., 1991; Kurpakus et al., 1991). The selective 
inhibition of hemidesmosomes produced by the tail-less/3, 
mutant  described  here  demonstrates  that  c~d34-mediated 
adhesion and hemidesmosome assembly can be separated 
experimentally, suggesting that the two phenomena have dis- 
tinct requirements. Thus, although engagement of t~,  by 
extracellular ligand may be a prerequisite for hemidesmo- 
some assembly, this process is likely to require a number of 
additional  steps  and  the  dominant  negative  tail-less  /3, 
subunit may interfere with one or more of these additional 
steps. 
We predict that, upon binding to laminin 5, the otd3, inte- 
grin  forms an  orderly aggregate  within the plane of the 
plasma membrane. Formation of the inner hemidesmosomal 
plaque would then be triggered either by a signal transmitted 
across the plasma membrane by the otd~, integrin or by a 
conformational change in the/3, cytoplasmic domain. This 
model offers potential mechanisms by which the tail-less/3, 
subunit can interfere with the assembly of  hemidesmosomes. 
Sin6e the radioligand-binding results indicate that the inte- 
grin containing the tail-less/34  binds in vitro to extracellu- 
lar  ligand  with an  intact affinity and the adhesion assay 
results suggest that it contributes efficiently to cell adhesion, 
it is likely that the mutant integrin and the wild-type endoge- 
nous molecule bind simultaneously to extracellular ligand so 
as to come in close proximity or even cocluster within the 
plasma membrane. The tail-less/3, may then interfere with 
hemidesmosome assembly by blocking the propagation of a 
conformational change across the membrane or the trans- 
mission of an intracellular signal by the wild-type integrin. 
In this model, tail-less/34 behaves similarly to growth fac- 
tor receptors deleted in their tyrosine kinase domain, which 
form signal transduction incompetent dimers with wild-type 
molecules (Schlessinger and Ullrich, 1992). These observa- 
tions support the notion that integrins interact within the 
plasma membrane during outside-in signal transduction. 
In this study we have also attempted to obtain a dominant 
negative effect by expressing a head-less/3, subunit. How- 
ever, this mutant molecule continued to accumulate in hemi- 
desmosomes without causing any apparent disruption, even 
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nous  ctd3~ integrin  and  did  not  interfere  with  ad~4-medi- 
ated  adhesion.  The  lack  of effect  of this  mutant integrin 
subunit is, at first glance, surprising. Mutant cadherin mole- 
cules of similar design have been shown to disrupt cell-cell 
adhesion in developing Xenopus embryos (Kintuer, 1992). In 
addition, it has been recently shown that single-subunit chi- 
meric  molecules  containing  the ~1,  /~3, or Bs cytoplasmic 
domain interfere with the ability of endogenous integrins to 
localize to focal adhesions, to mediate cell adhesion, migra- 
tion and matrix assembly (LaFlamme et al., 1994; Lukashev 
et al.,  1994), and to respond to intracellular regulatory sig- 
nals (Chert et al., 1994). Since these chimeras localize to fo- 
cal adhesions when expressed at low levels  (Geiger et al., 
1992; LaFlamme et al., 1992) and are capable of stimulating 
the activation of the focal adhesion kinase pp125 FAK (Aki- 
yama et al.,  1994;  Lukashev  et al.,  1994),  the dominant 
negative effect consequent to their high level expression has 
been attributed to the titration of intracellular factors essen- 
tial for integrin activity. At least some of these factors may 
be common to several integrins sharing the same ~/subunit, 
as the effects observed with single-subunit chimeras is trans- 
dominant (LaFlamme et al.,  1994; Lukashev et al.,  1994). 
Our negative results with the head-less 84 subunit suggest 
that  the  function  of  the  -6~4  integrin  may  be  regulated 
differently than that of other integrins. If intracelhilar regula- 
tors of o~dL exist, they may be different from those regulat- 
ing other integrins. Alternatively, they may not be present in 
804G cells in quantities low enough to allow titration. 
The ability of tail-less  B4 subunit to selectively  interfere 
with hemidesmosome  assembly  in  cultured cells  suggests 
that it may be possible to examine the in vivo function of 
hemidesmosomes in transgenic mice, without disrupting ini- 
tial cell  adhesion to the basement membrane mediated by 
ot6B4.  It  is  likely  that these junctions,  which  are  formed 
in  culture  with  relatively  slow  kinetics  (our  unpublished 
results), reinforce adhesion to the basement membrane and, 
indeed,  our electron microscopy observations indicate that 
cells  expressing the dominant negative  B,  subunit are sig- 
nificantly rounder and more detached from the culture sub- 
stratum than control cells. Finally, since a group of blistering 
skin diseases ale caused by genetic or epigenetic factors act- 
ing on hemidesmosomal components (Uitto and Christiano, 
1992), the introduction in transgenic mice of the dominant 
negative mutation described here may also provide informa- 
tion relevant to understanding the pathophysiology  of this 
class of diseases. 
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